sparfloxacin has been researched along with Pneumonia, Bacterial in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (85.71) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lazareva, NB | 1 |
| Hattori, H; Nakamura, S; Nakata, K; Okazaki, Y | 1 |
| Brumpt, I; Grassi, GG | 1 |
| Garau, J; Grassi, C; Hosie, J; Huchon, G; Legakis, N; Lode, H; Segev, S; Wijnands, G | 1 |
| Ibuki, E; Masuda, N; Miyoshi, H; Nishino, T; Otsuki, M; Takahashi, Y | 1 |
| Aubier, M; Gialdroni-Grassi, G; Hosie, J; Huchon, G; Legakis, N; Lode, H; Regamey, C; Segev, S; Tolstuchow, N; Vester, R; Wijnands, WJ | 1 |
| May, T; Portier, H; Proust, A | 1 |
| Rubinstein, E | 1 |
| Cars, O; Jean, C; Ortqvist, A; Saikku, P; Valtonen, M; Wahl, M | 1 |
| Ramirez, J; Talbot, GH; Townsend, L; Unowsky, J; Zhang, H | 1 |
| Dorr, MB; Lipsky, BA; Magner, DJ; Talbot, GH | 1 |
| Higashiyama, Y; Kohno, S; Maesaki, S; Miyazaki, Y; Tashiro, T; Tomiyama, Y; Tomono, K; Yong, B | 1 |
| Finch, RG | 1 |
| Hiroi, M; Hojyo, T; Kimura, K; Kobayashi, T; Matsumoto, T; Nakata, M; Ryo, H; Tateda, K; Toyama, K; Yamaguchi, K | 1 |
2 review(s) available for sparfloxacin and Pneumonia, Bacterial
| Article | Year |
|---|---|
Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studies.
Topics: Adult; Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Quinolones; Treatment Outcome | 1995 |
A review of worldwide experience with sparfloxacin in the treatment of community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Animals; Anti-Infective Agents; Bacterial Infections; Bronchitis; Chronic Disease; Clinical Trials as Topic; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia, Bacterial | 1999 |
6 trial(s) available for sparfloxacin and Pneumonia, Bacterial
| Article | Year |
|---|---|
Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Treatment Failure | 1995 |
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Bacterial; Quinolones; Streptococcus pneumoniae | 1996 |
Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia. French Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Ofloxacin; Penicillins; Pneumonia, Bacterial; Quinolones | 1996 |
Safety profile of sparfloxacin in the treatment of respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1996 |
Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Roxithromycin | 1996 |
Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones | 1999 |
6 other study(ies) available for sparfloxacin and Pneumonia, Bacterial
| Article | Year |
|---|---|
[Pharmacoeconomic efficiency of sparfloxacin use in empiric therapy of community-acquired pneumonia].
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cost-Benefit Analysis; Fluoroquinolones; Humans; Pneumonia, Bacterial | 2007 |
Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.
Topics: Animals; Anti-Infective Agents; Chlamydia Infections; Chlamydophila pneumoniae; Female; Fluoroquinolones; Leukopenia; Lung; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Bacterial; Quinolones | 1994 |
In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Naphthyridines; Piperazines; Pneumonia, Bacterial; Quinolones | 1996 |
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Data Interpretation, Statistical; Female; Fluoroquinolones; Heart Rate; Humans; Male; Middle Aged; Photosensitivity Disorders; Pneumonia, Bacterial; Quinolones; Sinusitis; Skin Diseases, Bacterial | 1999 |
[The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection].
Topics: Aged; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pneumonia, Bacterial; Treatment Outcome | 1999 |
[A case report of pulmonary nocardiosis successfully treated with a combination of sulfamethoxazole-trimethoprim (ST) and sparfloxacin].
Topics: Anti-Infective Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Middle Aged; Nocardia Infections; Pneumonia, Bacterial; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |